companydata.dkcompanydata.dk

AGC Biologics A/S: Financial statements 2022

CVR: 25950941

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

AGC Biologics A/S (CVR 25950941) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 2,517,996,000 and a net result of DKK 598,949,000 compared with DKK 571,735,000 the year before. That is an increase of 15.2% compared with the year before. The profit margin was 23.8%. Equity in the 2022 report amounted to DKK 661,277,000. The solvency ratio was 19.2%. The company had 894 employees in the financial year.

Revenue
DKK 2,517,996,000
Gross Profit
DKK 936,958,000
Profit/Loss
DKK 598,949,000
Equity
DKK 661,277,000
Total Assets
DKK 3,439,426,000
Employees
894

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20222.5B937M598.9M661.3M894
20212.2B831.9M571.7M633.6M730
20201.5B452M278.5M339.7M441
2019996.1M257.1M154.3M215.1M377
2018692.6M162.3M96.2M316.8M312

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on AGC Biologics A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Akira Nakamura joins the board of AGC Biologics A/SSep 1, 2022

As of September 1, 2022, Akira Nakamura has joined the board of directors of AGC Biologics A/S.

Hiroshi Nishimura leaves the board of AGC Biologics A/SSep 1, 2022

As of September 1, 2022, Hiroshi Nishimura has left the board of directors of AGC Biologics A/S.

AGC Biologics A/S: The 2021 annual report is outJun 27, 2022

AGC Biologics A/S has published its annual report for 2021. Revenue came to DKK 2,185,033,000, and the net result was DKK 571,735,000.

Andrea Celia Porchia joins AGC Biologics A/S as adm. dir.Mar 4, 2022

As of March 4, 2022, Andrea Celia Porchia is registered as adm. dir. of AGC Biologics A/S.

Kasper Møller steps down as director of AGC Biologics A/SMar 4, 2022

As of March 4, 2022, Kasper Møller has stepped down as director of AGC Biologics A/S.

About AGC Biologics A/S

AGC Biologics A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2001. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named CMC BIOLOGICS A/S and CMC BIOPHARMACEUTICALS A/S. The management consists of Kasper Møller. The board consists of Tadashi Murano (chair), Alberto Santagostino, Kasper Møller and Mai Iwaya. The company is owned by Asahi Glass Co., Ltd.. The company has 1,503 employees (2026). In 2025, the company reported revenue of DKK 1,959,639,000 and a net result of DKK -328,010,000 compared with DKK -115,005,000 the year before. Equity in the 2025 report amounted to DKK 312,021,000.

Source: annual report 2025, Danish Business Authority